Prostate Cancer Trial, Recruiting NCT06960291 Sponsor: University of Calgary Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06960291
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with cancer, or who have had a cancer diagnosis in the past
  • People who are 18 years of age or older
  • People who are able to take part in at least low-intensity physical activity (such as gentle movement or light exercise)
  • People who are awaiting cancer treatment, currently receiving cancer treatment (such as surgery, drug-based therapy, or radiation), have finished cancer treatment within the past 3 years, or — if it has been more than 3 years since treatment ended — people whose healthcare team has referred them because they have ongoing side effects from cancer or its treatment that exercise may help with
  • People who are able to read and sign a consent form written in English or French

Who may not be able to join:

  • People who have never had a cancer diagnosis
  • People under the age of 18
  • People who are not able to participate in even mild physical activity
  • People who are more than 3 years past completing cancer treatment and do not have ongoing side effects from cancer or its treatment that exercise could help manage
  • People who are not able to read or write in English
  • For online program formats: people without access to the internet or a computer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nicole Culos-Reed, PhD, University of Calgary

Phone: (403) 210-8482

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Calgary
Registry
ClinicalTrials.gov
Start date
11 March 2025
Est. completion
30 October 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Physical Activity Level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov